This study first aimed to verifying that the ApoB/ApoA1 ratio is strongly correlated with CHB disease progression, and its predictive potential is not correlated with potential risk factors (e.g., age, anti-hepatitis treatment, and duration of chronic hepatitis). The gene discussed is APOA1; the disease is hepatitis A virus infection.